Literature DB >> 25037274

Autoimmune diseases association study with the KIAA1109-IL2-IL21 region in a Tunisian population.

Dorra Bouzid1, Hajer Fourati, Ali Amouri, Isabel Marques, Olfa Abida, Nabil Tahri, Carlos Penha-Gonçalves, Hatem Masmoudi.   

Abstract

Autoimmune diseases (ADs) share several genetic factors resulting in similarity of disease mechanisms. For instance polymorphisms from the KIAA1109-interleukin 2 (IL2)-IL21 block in the 4q27 chromosome, has been associated with a number of autoimmune phenotypes. Here we performed a haplotype-based analysis of this AD related region in Tunisian patients. Ten single nucleotide polymorphisms (rs6534347, rs11575812, rs2069778, rs2069763, rs2069762, rs6852535, rs12642902, rs6822844, rs2221903, rs17005931) of the block were investigated in a cohort of 93 systemic lupus erythematosus (SLE), 68 ulcerative colitis (UC), 39 Crohn's disease (CD) patients and 162 healthy control subjects of Tunisian origin. In SLE population, haplotypes AGCAGGGTC, AGAAGAGTC, AGAAGGGTC and AGCCGAGTC provided significant evidence of association with SLE risk (p = 0.013, 0.028, 0.018 and 0.048, respectively). In the UC population, haplotype AGCCGGGTC provided a susceptibility effect for UC (p = 0.025). In the CD population, haplotype CAGGCC showed a protective effect against the development of CD (p = 0.038). Haplotype AAGGTT provided significant evidence to be associated with CD risk (p = 0.007). Our results support the existence of the associations found in the KIAA1109/IL2/IL21 gene region with ADs, thus confirms that the 4q27 locus may contribute to the genetic susceptibility of ADs in the Tunisian population.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25037274     DOI: 10.1007/s11033-014-3596-5

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  37 in total

1.  A haplotype map of the human genome.

Authors: 
Journal:  Nature       Date:  2005-10-27       Impact factor: 49.962

2.  Whole-genome patterns of common DNA variation in three human populations.

Authors:  David A Hinds; Laura L Stuve; Geoffrey B Nilsen; Eran Halperin; Eleazar Eskin; Dennis G Ballinger; Kelly A Frazer; David R Cox
Journal:  Science       Date:  2005-02-18       Impact factor: 47.728

3.  Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology.

Authors:  Mark S Silverberg; Jack Satsangi; Tariq Ahmad; Ian D R Arnott; Charles N Bernstein; Steven R Brant; Renzo Caprilli; Jean-Frédéric Colombel; Christoph Gasche; Karel Geboes; Derek P Jewell; Amir Karban; Edward V Loftus; A Salvador Peña; Robert H Riddell; David B Sachar; Stefan Schreiber; A Hillary Steinhart; Stephan R Targan; Severine Vermeire; B F Warren
Journal:  Can J Gastroenterol       Date:  2005-09       Impact factor: 3.522

4.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

Review 5.  Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation.

Authors:  Warren J Leonard; Rosanne Spolski
Journal:  Nat Rev Immunol       Date:  2005-09       Impact factor: 53.106

6.  Fine-mapping and transethnic genotyping establish IL2/IL21 genetic association with lupus and localize this genetic effect to IL21.

Authors:  Travis Hughes; Xana Kim-Howard; Jennifer A Kelly; Kenneth M Kaufman; Carl D Langefeld; Julie Ziegler; Elena Sanchez; Robert P Kimberly; Jeffrey C Edberg; Rosalind Ramsey-Goldman; Michelle Petri; John D Reveille; Javier Martín; Elizabeth E Brown; Luis M Vilá; Graciela S Alarcón; Judith A James; Gary S Gilkeson; Kathy L Moser; Patrick M Gaffney; Joan T Merrill; Timothy J Vyse; Marta E Alarcón-Riquelme; Swapan K Nath; John B Harley; Amr H Sawalha
Journal:  Arthritis Rheum       Date:  2011-06

7.  IL-21 has a pathogenic role in a lupus-prone mouse model and its blockade with IL-21R.Fc reduces disease progression.

Authors:  Deborah Herber; Thomas P Brown; Spencer Liang; Deborah A Young; Mary Collins; Kyri Dunussi-Joannopoulos
Journal:  J Immunol       Date:  2007-03-15       Impact factor: 5.422

8.  A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity.

Authors:  Carola G Vinuesa; Matthew C Cook; Constanza Angelucci; Vicki Athanasopoulos; Lixin Rui; Kim M Hill; Di Yu; Heather Domaschenz; Belinda Whittle; Teresa Lambe; Ian S Roberts; Richard R Copley; John I Bell; Richard J Cornall; Christopher C Goodnow
Journal:  Nature       Date:  2005-05-26       Impact factor: 49.962

Review 9.  The role of IL-21 in regulating B-cell function in health and disease.

Authors:  Rachel Ettinger; Stefan Kuchen; Peter E Lipsky
Journal:  Immunol Rev       Date:  2008-06       Impact factor: 12.988

10.  Novel association of the interleukin 2-interleukin 21 region with inflammatory bowel disease.

Authors:  Ana Márquez; Gisela Orozco; Alfonso Martínez; Rogelio Palomino-Morales; Miguel Fernández-Arquero; Juan Luis Mendoza; Carlos Taxonera; Manuel Díaz-Rubio; María Gómez-García; Antonio Nieto; Miguel A López-Nevot; Emilio G de la Concha; Javier Martín; Elena Urcelay
Journal:  Am J Gastroenterol       Date:  2009-05-26       Impact factor: 10.864

View more
  4 in total

1.  IL-2 gene polymorphisms affect tacrolimus response in myasthenia gravis.

Authors:  Yang Shumei; Li Yi; Meng Huanyu; Li Zhibin; Jin Wanlin; Xu Liqun; Yang Huan
Journal:  Eur J Clin Pharmacol       Date:  2019-02-07       Impact factor: 2.953

2.  Genetic colocalization atlas points to common regulatory sites and genes for hematopoietic traits and hematopoietic contributions to disease phenotypes.

Authors:  Christopher S Thom; Benjamin F Voight
Journal:  BMC Med Genomics       Date:  2020-06-29       Impact factor: 3.063

3.  Apremilast Pharmacogenomics in Russian Patients with Moderate-to-Severe and Severe Psoriasis.

Authors:  Dmitry A Verbenko; Arfenya E Karamova; Olga G Artamonova; Dmitry G Deryabin; Alexander Rakitko; Alexandr Chernitsov; Anna Krasnenko; Artem Elmuratov; Victoria S Solomka; Alexey A Kubanov
Journal:  J Pers Med       Date:  2020-12-29

4.  Comparison of cytokine and gene activities in tissue and blood samples of patients with celiac disease.

Authors:  Ensieh KhalKhal; Zahra Razzaghi; Hakimeh Zali; Ayad Bahadorimonfared; Majid Iranshahi; Mohammad Rostami-Nejad
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2019
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.